Sailong Pharmaceutical Group Co.,Ltd.

002898

CNE1000032S5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
8.53 ^CNY	-0.93%		-0.70%	-38.94%

Jul. 02	Sailong Pharmaceutical's Anti-Cancer Chemotherapy Drug Gets Marketing Nod	MT
Jun. 20	Sailong Pharmaceutical Group Co.,Ltd. Announces Cash Dividend on Share A for the Year 2023, Payable on June 28, 2024	CI

Sailong Pharmaceutical Group Co.,Ltd. Announces Cash Dividend on Share A for the Year 2023, Payable on June 28, 2024

June 20, 2024 at 03:37 pm EDT

Sailong Pharmaceutical Group Co.,Ltd. announced Cash dividend/10 shares (tax included): CNY 0.20000000 on share A for the year 2023. Record date: 27 June 2024, Ex-date: 28 June 2024, Payment date: 28 June 2024.

Latest news about Sailong Pharmaceutical Group Co.,Ltd.

Sailong Pharmaceutical's Anti-Cancer Chemotherapy Drug Gets Marketing Nod	Jul. 02	MT
Sailong Pharmaceutical Group Co.,Ltd. Announces Cash Dividend on Share A for the Year 2023, Payable on June 28, 2024	Jun. 20	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections	Apr. 08	CI
Sailong Pharma's Unit Gets Nod to Market Pregabalin	Mar. 08	MT
Sailong Pharma Gets Registration Certificate for Pregabalin Capsules	Mar. 04	MT
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Zhuhai Sailong Pharmaceutical : Sailong Pharmaceutical Adopts New Name	21-09-07	MT
Zhuhai Sailong Pharmaceutical Co.,Ltd. has Changed its Name to Sailong Pharmaceutical Group Co., Ltd	21-09-03	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Wu Gulin signed share transfer agreement to acquire Hunan Shenglong Real Estate Co., Ltd. from Zhuhai Sailong Pharmaceutical Co.,Ltd. for CNY 10.2 million.	21-05-17	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Proposes No Final Dividend for 2020	21-04-30	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-27	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-10	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Implementation of A Share Dividend for the Year 2019, Payable on 16 July 2020	20-07-08	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2019	20-05-21	CI

Chart Sailong Pharmaceutical Group Co.,Ltd.

Duration

Period

Chart Sailong Pharmaceutical Group Co.,Ltd.

More charts

Company Profile

Sailong Pharmaceutical Group Co Ltd, formerly Zhuhai Sailong Pharmaceutical Co Ltd, is a China-based company principally engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations, as well as providing technical services. The Companyâs main products include monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others. Through its subsidiaries, the Company is also engaged in the sales of scraps, provision of technical services and sales promotion. The Company mainly conducts its businesses with domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SAILONG PHARMACEUTICAL GROUP CO.,LTD.	-38.94%	209M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+25.40%	45.54B
OTSUKA HOLDINGS CO., LTD.	+37.38%	24.51B
SANDOZ GROUP AG	+27.12%	16.48B
CIPLA LIMITED	+21.19%	14.66B
ZYDUS LIFESCIENCES LIMITED	+71.91%	14.3B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.65%	6.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.08%	5.87B
STADA ARZNEIMITTEL	-8.87%	5.73B